Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

The paper concludes that animal models help in understanding hair loss causes and developing new treatments.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Certain finger length ratios and body hair patterns may predict side effects from birth control pills in women.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Sex hormones and antiandrogens can either stimulate or inhibit human hair follicle cell growth depending on the dose.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.